Eli Lilly Says Experimental Alzheimer’s Drug Reduces Brain Plaque in Early Study
Eli Lilly’s experimental Alzheimer’s drug lowered levels of brain plaque in patients who are in the earliest stages of the devastating disease, initial data found. A higher dose of the